Alizarin, an Agonist of AHR Receptor, Enhances CYP1A1 Enzyme Activity and Induces Transcriptional Changes in Hepatoma Cells

The phytopigment alizarin was previously characterized as an anti-tumor drug owing to its antioxidant or antigenotoxic activities. However, the safety of alizarin is currently still under dispute. In this study, we explored the activity of alizarin in the AHR-CYP1A1 pathway and analyzed the transcri...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Shengxian, Bo, Haimei, Zhang, Yue, Zhen, Hongcheng, Zhong, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650112/
https://www.ncbi.nlm.nih.gov/pubmed/37959792
http://dx.doi.org/10.3390/molecules28217373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650112/
https://www.ncbi.nlm.nih.gov/pubmed/37959792
http://dx.doi.org/10.3390/molecules28217373

Ejemplares similares